Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Abstract: Equivariant quantum graph neural networks (EQGNNs) offer a potentially powerful method to process graph data. However, existing EQGNN models only consider the permutation symmetry of graphs, ...